• 1
    Xu F, Markowitz LE, Gottlieb SL, Berman SM. Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States. Am J Obstet Gynecol 2007;196:43.e1–6.
  • 2
    Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. J Am Med Assoc 2006;296:96473.
  • 3
    Fleming D, McQuillan G, Johnson R, Nahmias AJ, Aral SO, Lee FK, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:110511.
  • 4
    Bryson YJ, Dillon M, Bernstein DI, Radolf J, Zakowski P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993;167:9426.
  • 5
    Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic HSV-2 seropositive persons. N Engl J Med 2000;342:84450.
  • 6
    Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999;12:18.
  • 7
    Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197202.
  • 8
    Mertz GJ, Schmidt O, Jourden JL, Guinan ME, Remington ML, Fahnlander A, et al. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985;12:339.
  • 9
    Mertz GJ, Coombs RW, Ashley R, Jourden J, Remington M, Winter C, et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis 1988;157:116977.
  • 10
    Langenberg A, Corey L, Ashley R, Leong W, Straus S. A prospective study of new infections with herpes simplex virus type 1 and type 2. N Engl J Med 1999;341:14328.
  • 11
    Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital HSV-2 shedding in immunocompetent women. J Clin Invest 1997;99:10927.
  • 12
    Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333:7705.
  • 13
    Mark KE, Wald A, Magaret AS, Selke S, Olin L, Huang ML, et al. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis 2008;198:11419.
  • 14
    Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003;30:797800.
  • 15
    Ribes JA, Steele AD, Seabolt JP, Baker DJ. Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population. J Clin Microbiol 2001;39:33215.
  • 16
    Mertz GJ, Rosenthal SL, Stanberry LR. Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? Sex Transm Dis 2003;30:8012.
  • 17
    Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000;181: 14547.
  • 18
    Forsgren M. Genital herpes simplex virus infection and incidence of neonatal disease in Sweden. Scand J Infect Dis Suppl 1990;69:3741.
  • 19
    Patrick DM, Dawar M, Cook DA, Krajden M, Ng HC, Rekart ML. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transm Dis 2001;28:4248.
  • 20
    Corey L, Handsfield HH. Genital herpes and public health: addressing a global problem. JAMA 2000;283:7914.
  • 21
    Haddow LJ, Dave B, Mindel A, McPhie KA, Chung C, Marks C, et al. Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003. Sex Transm Infect 2006;82:2559.
  • 22
    Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000;76:1837.
  • 23
    Morris SR, Bauer HM, Samuel MC, Gallagher D, Bolan G. Neonatal herpes morbidity and mortality in California, 1995–2003. Sex Transm Dis 2008;35:148.
  • 24
    Gutierrez KM, Halpern MSF, Maldonado Y, Arvin AM. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis 1999;180:199202.
  • 25
    Whitley R, Davis EA, Suppapanya N. Incidence of neonatal herpes simplex virus infections in a managed-care population. Sex Transm Dis 2007;34:7048.
  • 26
    Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:2039.
  • 27
    Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr Perinat Epidemiol 1996;10:43242.
  • 28
    Kropp RY, Wong T, Cormier L, Ringrose A, Burton S, Embree JE, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 2006;117:195562.
  • 29
    Cowan FM, Humphrey JH, Ntozini R, Mustasa K, Morrow P, Iliff P. Maternal herpes simplex virus type 2 infection, syphilis and risk of intra-partum transmission of HIV-1: results of a case control study. AIDS 2008;22:193201.
  • 30
    Sheffield JS, Wendel GD, McIntire DD, Norgard MV. Effect of genital ulcer disease on HIV-1 co receptor expression in the female genital tract. J Infect Dis 2007;196:150916.
  • 31
    Chen KT, Segu M, Lumey LH, Kuhn L, Carter RJ, Bulterys SM, Abrams EJ. Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus. Obstet Gynecol 2005;106:13418.
  • 32
    Kimberlin D, Lin C-Y, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001;108:2239.
  • 33
    Kimberlin D, Lin C-Y, Jacobs RF, Powell DA, Corey L, Gruber WC, et al. The safety and efficacy of high-dose acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001;108:2308.
  • 34
    Kimberlin DW. Herpes simplex virus infections in neonates and early childhood. Semin Pediatr Infect Dis 2005;16:27181.
  • 35
    Xu F, Schillinger JA, Sternberg MR, Johnson RE, Lee FK, Nahmias AJ, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988–1994. J Infect Dis 2002;185:101924.
  • 36
    Halpern-Felsher BL, Cornell JL, Kropp RY, Tschann JM. Oral versus vaginal sex among adolescents: perceptions, attitudes, and behavior. Pediatrics 2005;115:84551.
  • 37
    Engelberg R, Carrell D, Krantz E, Corey L, Wald A. Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis 2003;30:1747.
  • 38
    Corey L, Whitley RJ, Stone EF, Mohan K. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet 1988;6:14.
  • 39
    Ashley R. Performance and use of HSV type-specific serology test kits. Herpes 2002;9:3845.
  • 40
    ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007;109:148998.
  • 41
    Gynaecologists RCoOa. Managment of genital herpes in pregnancy. Green-top Guideline No 30 2007:19.
  • 42
    Schalkwyk J, Amiri N, Lalji S, Gardella C, Wald A, Money D. Acceptance of a rapid herpes test in labour: survey of attitudes of patients and health care providers. J Obstet Gynaecol Can 2008;30:77680.
  • 43
    Edmiston N, O’Sullivan M, Charters D, Chuah J, Pallis L. Study of knowledge of genital herpes infection and attitudes to testing for genital herpes among antenatal clinic attendees. Aust N Z J Obstet Gynaecol 2003;43:3513.
  • 44
    Rosenthal SL, Zimet GD, Leichliter JS, Stanberry LR, Fife KH, Tu W et al. The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection. Sex Transm Infect 2006;82:1547; discussion 7–8.
  • 45
    Richards J, Scholes D, Caka S, Drolette L, Magaret AM, Yarbro P, et al. HSV-2 serologic testing in an HMO population: uptake and psychosocial sequelae. Sex Transm Dis 2007;34:71825.
  • 46
    Money D, Steben M. Guidelines for the mangement of herpes simplex virus in pregnancy. J Obstet Gynaecol Can 2008;30:5149.
  • 47
    Sheffield JS, Hill JB, Hollier LM, Laibl VR, Roberts SW, Sanchez PJ, et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet Gynecol 2006;108:1417.
  • 48
    Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003;102:1396403.
  • 49
    Gardella C, Brown Z, Wald A, Selke S, Zeh J, Morrow RA, et al. Risk factors for herpes simplex virus transmission to pregnant women: a couples study. Am J Obstet Gynecol 2005;193:18919.
  • 50
    Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:1120.
  • 51
    Gardella C, Krantz E, Daruthayan C, Drolette L, Corey L, Wald A. The acceptance of HSV-testing partners of HSV-2 seronegative pregnant women. Sex Transm Dis 2009;36:2115.
  • 52
    Gardella C, Huang ML, Wald A, Magaret A, Selke S, Morrow R, et al. Rapid polymerase chain reaction assay to detect herpes simplex virus in the genital tract of women in labor. Obstet Gynecol 2010;115:120916.